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INTRODUCTION
Phagocytosis of zymosan particles by human
peripheral blood polymorphonuclear leukocytes
(PMN) results in the release of lysosomal enzymes
into the extracellular medium (1) and enhanced
glucose oxidation and lactate production (2) .
The antibiotic, cytochalasin B (CB), inhibits
phagocytosis by PMN (3, 4), presumably by
interfering with the membrane-associated net-
work of microfilaments (5). CB is therefore useful
in studies of the interrelationship between phago-
cytosis and metabolic changes in stimulated
PMN.
This study confirms earlier reports that CB
inhibits phagocytosis by PMN (3, 4, 6) and
carbohydrate metabolism in phagocytosing PMN
(4, 6, 7). The release of the lysosomal enzyme,
,3-glucuronidase, however, was moderately stimu-
lated by CB under conditions which resulted in
almost total inhibition of phagocytosis .
MATERIALS AND METHODS
Zymosan (Sigma Chemical Co., St. Louis, Mo.) was
incubated for 1 h at 37°C with plasma from the donor
of cells used in the experiment, collected by cen-
trifugation, and suspended in Krebs-Ringer phos-
phate buffer (KRP) (8) . CB (Imperial Chemical In-
dustries, Macclesfield, Cheshire, England) was dis-
solved in dimethylsulfoxide (DMSO) before addition
to the incubation medium. [1_14Qglucose and
[carboxyl-14C]inulin were purchased from Amersham/
Searle Corp. (Arlington Heights, Ill.) .
Heparinized blood (10 U heparin/ml blood) was
obtained from normal women. The donors abstained
from all dietary sources of methyl xanthines on the
morning blood was drawn. After erythrocytes were
allowed to sediment at 37°C for 2-3 h, the plasma
(containing leukocytes) was removed and centrifuged
at 250 g for 10 min. The cell pellet was suspended in
plasma, and 3 vol of 0.87°/0 NH4C1 were added to
lyse remaining erythrocytes . Leukocytes were then
washed twice in KRP and suspended in buffer for
incubation. Suspensions (ca. 108 cells/ml) contained
95-98% PMN.
Separate aliquots of cell suspensions were used for
measurements of inulin uptake and /3-glucuronidase
release, and for measurement of 14002 and lactate
production. 0.2 ml of cell suspension was added to
polyethylene test tubes containing 5 gl of DMSO
with the desired concentration of CB and preincu-
bated for 30 min. 0.2 ml of KRP containing glucose
(5 mM, final concentration) with or without zymosan
(1 mg/ml, final concentration) was then added, and
incubation was continued for an additional 30 min
for metabolic measurements. Trace concentrations of
[1-14C]glucose (0.5 MCi/ml) or [carboxyl-14C]inulin (1
gCi/ml) were present in the medium. In experiments
testing the effect of glucose on [14C]inulin uptake and
(3-glucuronidase release, cells were incubated for 30
min in the absence or presence of glucose (5 mM) .
Cell suspensions were incubated in polyethylene
test tubes at 37°C with continuous shaking. When
[14C] inulin was present, the incubation was stopped
by chilling the tubes in an ice bath and the addition
of chilled KRP containing inulin, I mg/ml . The cell
suspension was centrifuged at 250g for 5 min, and
the supernatant was saved for determination of
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237(3-glucuronidase activity, using p-nitrophenyl glucu-
ronide as substrate (9) . In some experiments, total
enzyme activity was determined in selected tubes by
the addition of Triton-X100 (1) . For measurement of
[14C]inulin uptake, the cell pellet was washed as de-
scribed by Berger and Karnovsky (10), dissolved in
0.1 ml of 2 N NaOH, and diluted with 1 .4 ml H20.
Aliquots were taken for counting in a 3a40 liquid
scintillator (Research Products International Corp .,
Elk Grove Village, Ill.) and for protein determina-
tions (11). The incubation of cell suspensions con-
taining [1-14C]glucose was stopped by the injection of
0.5 ml of 1 N HC1O4 into the medium. t4C02 was
collected in hyamine and counted (12) . Lactate was
measured in the deproteinized fluid (13).
RESULTS
The results of preliminary experiments indicated
that preincubation of cells with CB, 50 µg/ml,
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did not alter baseline j -glucuronidase release
from nonphagocytosing cells, although the anti-
biotic has been shown to inhibit the metabolism
of glucose by resting cells (4, 6, 7) . Zymosan
added to cells preincubated without CB, stimu-
lated the uptake of [14C]inulin and the release of
$-glucuronidase from cells, as well as the oxida-
tion of [l-14C]glucose to 14002 and the production
of lactate. Previous incubation with CB in con-
centrations ranging from 2 to 60 µg/ml resulted
in inhibition of zymosan-stimulated [14C]inulin
uptake, and 14G02 and lactate production. The
release of f3-glucuronidase was slightly stimulated
at all concentrations of the antibiotic used (Fig. 1).
CB inhibits the transport of 2-deoxy-D-glucose
into horse leukocytes (14), and of glucose into
hepatoma cells (15) . Our findings could have re-
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CYTOCHALASIN B, EcG/ML
FIGURE 1 Effect of preincubation with CB on [14C]inulin uptake, f3-glucuronidase release, glucose oxi-
dation, and lactate production. Human peripheral blood leukocytes (98°%o PMN) were incubated for 30
min with CB at the concentrations indicated. An equal volume of zymosan suspension containing either
[I4C]inulin or [1-14C]glucose was then added. Metabolic measurements were then made after an addi-
tional 30 min incubation period . Means of triplicate determinations from cells incubated with (closed
circles) or without (open circles) zymosan are plotted. /3-glucuronidase activity was measured by estimat-
ing the rate of production of p-nitrophenol (PNP) from p-nitrophenyl glucuronide .
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100
-o 0TABLE I
Effect of Glucose on [14C]Inulin Uptake and
(3-Glucuronidase Release
[14C]Inulin uptake, cpm/mg cell protein
(mean f SE)
No glucose
	
16 .0 f 0.62 160 f 9 .0
Glucose, 5 mM 13 .5 t 2 .8
	
191 f 11
j3-Glucuronidase release, 1 / 0 total activity
(mean zh SE)
No glucose
	
2 .37 f 0.10
	
11 .3 t 0 .15
Glucose, 5 mM
	
1 .87 f 0.10
	
11 .7 t 0.13
Human peripheral blood leukocytes (95% PMN)
were incubated for 30 min with [14C]inulin. Glu-
cose and zymosan were present where indicated .
The means f standard error of triplicate deter-
minations are given.
suited from inhibition of glucose utilization by
cells incubated with CB. Therefore, we tested the
effect of glucose on zymosan-stimulated [14C]-
inulin uptake and jQ-glucuronidase release. Glu-
cose had no significant effect on either inulin
uptake or enzyme release by resting or phagocy-
tosing cells (Table I) .
DISCUSSION
CB has been shown to inhibit phagocytosis by
human PMN as measured by the uptake and
killing of bacteria (3, 4, 6) or by the direct exami-
nation of cells incubated with particles (4, 6) .
The difficulties inherent in these methods have
been discussed (4, 10). We have elected to use
the uptake of [14C]inulin into cells as an index of
phagocytosis, as described previously (10). This
large molecular weight compound presumably
enters cells in the water taken into the phagocytic
vesicle. Water also enters cells during the process
of pinocytosis. The uptake of [19C]inulin, there-
fore, serves as an index of endocytosis, and is not
specific for either phagocytosis or pinocytosis
(10) . Since endocytosis of either type is associated
with metabolic changes (16), it is reasonable to
relate PMN metabolism and function to [14C]-
inulin uptake.
Three possible mechanisms have been proposed
for the release of lysosomal enzymes from phago-
cytosing cells (1) . The first, release of enzymes
after cell death, cannot account for release of
lysosomal enzymes from PMN phagocytosing
I
	
No zymosan
	
I Zymosan, 1 mg/ml
zymosan, since lactic dehydrogenase, a nonlyso-
somal cytoplasmic enzyme, is not released from
cells in response to zymosan (1).
A second mechanism which has been proposed
is that of "regurgitation during feeding ." Elec-
tron microscope examination of rabbit neutrophils
phagocytosing zymosan particles (17) has sug-
gested that lysosomes fuse with the phagocytic
vesicle as it forms during particle uptake . The lyso-
somes appear to discharge their content of en-
zymes into the vesicle. Enzymes are then extruded
through the unclosed "mouth" of the phagocytic
vesicle. Henson (17) has suggested that neutro-
phils which have phagocytosed many particles
"run out of energy" and become inefficient in
closing off developing phagocytic vesicles . Lyso-
somal enzymes which have been extruded into
the vesicle are allowed to leak out into the medium.
Since CB inhibits glucose metabolism (14, 15), it is
possible that the early phases of phagocytosis occur
in the presence of CB, but that the antibiotic de-
prives the cells of sufficient energy to close off the
mouth of the vesicle . However, the observation
that complete deprivation of the cells of exoge-
nous glucose does not mimick the effects of CB
argues against this possibility .
We favor a third mechanism, "directed exocy-
tosis," or "reverse endocytosis," proposed for
the stimulation of release of enzyme by zymosan.
Phagocytosis is apparently not required for the
particles to stimulate enzyme release. It thus
appears possible that zymosan, by coming into
contact with cell membrane receptors, triggers
lysosomal enzyme release without the requirement
for the development of a phagocytic vesicle .
Orci et al. observed that CB enhances glucose-
induced secretion of insulin by isolated rat pan-
creatic islets (18) . They suggested that the net-
work of microfilaments of the beta cell might
act as a barrier which denies the insulin-secretory
granules access to the cell membrane. CB, by
disrupting the function of this network, could cause
enhancement of insulin secretion. A similar mecha-
nism could explain the moderate enhancement of
zymosan-stimulated (3-glucuronidase release from
PMN.
SUMMARY
Phagocytosis of zymosan by human peripheral
blood PMN, measured by the uptake of [14C]inulin
from the incubation medium, was inhibited by
CB. CB also decreased zymosan-stimulated oxida-
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239tion of [1-14C]glucose to 14CO2 and production
of lactate, but moderately stimulated the release
of ,3-glucuronidase . The results suggest that re-
lease of fl3-glucuronidase from cells exposed to
zymosan does not require phagocytosis of the
particles.
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